Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Frontiers in Oncology|October 5, 2017
Resources for Interpreting Variants in Precision Genomic Oncology ApplicationsHsinyi Tsang, KanakaDurga Addepalli, Sean R DavisAIDS (London, England)|June 24, 2003
Pathways for the emergence of multi-dideoxynucleoside-resistant HIV-1 variantsShintaro Matsumi, Pope Kosalaraksa, Hsinyi Tsang, et al.Cancer Cell|April 10, 2007
Modeling synovial sarcoma: timing is everythingSean R Davis, Paul S MeltzerAntiviral Research|February 23, 2011
Within-host co-evolution of Gag P453L and protease D30N/N88D demonstrates virological advantage in a highly protease inhibitor-exposed HIV-1 caseJunko Shibata, Wataru Sugiura, Hirotaka Ode, et al.Viruses|September 15, 2016
On the Selective Packaging of Genomic RNA by HIV-1Mauricio Comas-Garcia, Sean R Davis, Alan ReinBMC Bioinformatics|March 24, 2016
caOmicsV: an R package for visualizing multidimensional cancer genomic dataHongen Zhang, Paul S Meltzer, Sean R DavisElife|February 23, 2018
C/EBPδ drives interactions between human MAIT cells and endothelial cells that are important for extravasationChang Hoon Lee, Hongwei H Zhang, Satya P Singh, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2015
PLZF regulates CCR6 and is critical for the acquisition and maintenance of the Th17 phenotype in human cellsSatya P Singh, Hongwei H Zhang, Hsinyi Tsang, et al.BMC Bioinformatics|January 18, 2013
SRAdb: query and use public next-generation sequencing data from within RYuelin Zhu, Robert M Stephens, Paul S Meltzer, et al.The Journal of Biological Chemistry|December 14, 2001
Amino acid substitutions in Gag protein at non-cleavage sites are indispensable for the development of a high multitude of HIV-1 resistance against protease inhibitorsHiroyuki Gatanaga, Yasuhiro Suzuki, Hsinyi Tsang, et al.Pageof 5